SinoMab BioScience Market Cap

SinoMab BioScience has a market cap or net worth of 1.57 billion as of July 9, 2026. Its market cap has decreased by -43.44% in one year.

Market Cap

1.57B

Enterprise Value

1.52B

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

1.19

Market Cap Chart

Since November 12, 2019, SinoMab BioScience's market cap has decreased from 6.04B to 1.57B, a decrease of -74.05%. That is a compound annual growth rate of -18.33%.

Market Cap History

Date	Market Cap	% Change
Jul 9, 2026	1.57B	-15.67%
Dec 31, 2025	1.86B	56.14%
Dec 31, 2024	1.19B	-31.56%
Dec 29, 2023	1.74B	-7.18%
Dec 30, 2022	1.87B	-34.91%
Dec 31, 2021	2.88B	-37.83%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Nov 12, 2019	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Clover Biopharmaceuticals	2.22B
Frontage Holdings	2.17B
PegBio	2.15B
AIM Vaccine	2.09B
Mabpharm	1.75B
Hangzhou Jiuyuan Genetic Biopharmaceutical	1.66B
ImmuneOnco Biopharmaceuticals (Shanghai)	1.60B
HighTide Therapeutics	1.54B

Market Cap Rankings